Overview
Product nameGALE proteinSee all GALE proteins and peptides ...
Protein descriptionRecombinant full length Human GALE (amino acids 1-348) with N terminal His tag; 368 amino acids, MWt 40.4kDa (UniProt Q14376).
Uniprot accessionQ14376
Molecular weight40.400kDa inclusive of tags
Protein length348 amino acids
Expression hostE. coli
Properties
Purity> 95
% by SDS-PAGE
Purification notesab96767 is purified using conventional chromatography techniques.
E.C. Number5.1.3.2
FormLiquid
Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
Storage bufferPreservative: None
Constituents: 10% Glycerol, 0.1M Sodium chloride, 5mM DTT, 20mM Tris HCl, 1mM EDTA, pH 8.0
Concentration information loading...
SequenceMGSSHHHHHHSSGLVPRGSHMAEKVLVTGGAGYIGSHTVL ELLEAGYLPVVIDNFHNAFRGGGSLPESLRRVQELTGRSV EFEEMDILDQGALQRLFKKYSFMAVIHFAGLKAVGESVQK PLDYYRVNLTGTIQLLEIMKAHGVKNLVFSSSATVYGNPQ YLPLDEAHPTGGCTNPYGKSKFFIEEMIRDLCQADKTWNA VLLRYFNPTGAHASGCIGEDPQGIPNNLMPYVSQVAIGRR EALNVFGNDYDTEDGTGVRDYIHVVDLAKGHIAALRKLKE QCGCRIYNLGTGTGYSVLQMVQAMEKASGKKIPYKVVARR EGDVAACYANPSLAQEELGWTAALGLDRMCEDLWRWQKQN PSGFGTQA
Research Areas
Applications
Our Abpromise guarantee covers the use of
ab96767
in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|
Application
|
Notes |
| MS |
MS: Use at an assay dependent dilution. |
| SDS-PAGE |
SDS-PAGE: Use at an assay dependent dilution. |
Application notesThis peptide can be used with studies using ab153824,ab155277 and ab155997.
Protein info
-
Alternative names
FLJ95174FLJ97302Galactose 4 epimerase UDP
GalactowaldenasegalEGALE_HUMANOTTHUMP00000002991OTTHUMP00000002994OTTHUMP00000037931OTTHUMP00000044857SDR1E1short chain dehydrogenase/reductase family 1E member 1UDP galactose 4 epimeraseUDP galactose 4' epimeraseUDP glucose 4 epimeraseUDP-galactose 4-epimeraseUDP-glucose 4-epimerase
see all
FunctionCatalyzes two distinct but analogous reactions: the epimerization of UDP-glucose to UDP-galactose and the epimerization of UDP-N-acetylglucosamine to UDP-N-acetylgalactosamine.
PathwayCarbohydrate metabolism; galactose metabolism.
Involvement in diseaseDefects in GALE are the cause of epimerase-deficiency galactosemia (EDG) [MIM:230350]; also known as galactosemia type 3. Clinical features include early-onset cataracts, liver damage, deafness and mental retardation. There are two clinically distinct forms of EDG. (1) A benign, or 'peripheral' form with no detectable GALE activity in red blood cells and characterized by mild symptoms. Some patients may suffer no symptoms beyond raised levels of galactose-1-phosphate in the blood. (2) A much rarer 'generalized' form with undetectable levels of GALE activity in all tissues and resulting in severe features such as restricted growth and mental development.
Sequence similaritiesBelongs to the sugar epimerase family.
References for GALE protein (ab96767)
ab96767
has not yet been referenced specifically in any publications.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"